MarketInOut Stock Screener Log In | Sign Up
 

Creative Medical Technology Holdings Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Creative Medical Technology Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.62 mln
Float6.56 mln
Earnings Date11/06/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-3.96
Highly reliable

Relative Strength

26 / 100
Underperforming

Debt / Equity

0.00
Debt-free

Pre-Tax Margin

-201,286%
Severely loss-making

ROE

-87.05
Deeply negative

Business Description

Creative Medical Technology Holdings is a US-based biotechnology company developing treatments across a wide range of medical areas, including sexual health, diabetes, back pain, infertility, and neurological conditions. Its current products include CaverStem for erectile dysfunction and FemCelz to address female sexual health concerns, while its pipeline features several cell-based therapies at various stages of development. The company is also working on solutions for organ transplant rejection, kidney and liver failure, heart attacks, and Parkinson's disease. It operates out of Phoenix, Arizona.

Key Fundamentals

EPS-2.07
ROE-87.05
RPS0.00
ROIC-1,461
ROA-82.55
EBITDA, mln-5.93
EV / EBITDA1.13
EV / EBIT1.11
Revenue, mln0.00

Quote Details

Last 0.74
Change -0.034 (-4.39%)
Open 0.7651
Volume 24,510
Turnover 18,137
Average Volume 120,615

Financial Ratios

Pre-Tax Profit Margin-201,286
Leverage Ratio1.08
Current Ratio12.91
Price / Book0.70
Price / Tangible Book0.73
Debt / Equity0.00
Price / Sales935

Financial Strength

Altman Z-Score-6.57
Piotroski F-Score 2 / 9
Beneish M-Score-3.96
Short Ratio0.14
Short % of Float2.18

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.13% 55 / 100   
1 Month -23.71% 18 / 100   
2 Months -14.25% 34 / 100   
6 Months -67.83% 6 / 100   
1 Year -81.07% 6 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog